NPI: 1184725525 · ROCHESTER, NY 14642 · Neurology Physician · NPI assigned 09/26/2006
Authorized official HETTERICH, JILL controls 20+ related entities in our dataset. Read more
| Authorized Official | HETTERICH, JILL (SENIOR DIRECTOR OF FINANCE URMFG) |
| NPI Enumeration Date | 09/26/2006 |
Other providers sharing the same authorized official: HETTERICH, JILL
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 370 | $42K |
| 2019 | 178,493 | $8.55M |
| 2020 | 161,837 | $8.39M |
| 2021 | 203,720 | $11.58M |
| 2022 | 205,663 | $12.33M |
| 2023 | 222,586 | $12.64M |
| 2024 | 132,452 | $8.17M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90791 | Psychiatric diagnostic evaluation | 5,832 | 4,682 | $7.80M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21,765 | 20,262 | $3.68M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14,935 | 14,332 | $2.80M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 12,224 | 11,459 | $2.67M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 13,946 | 12,929 | $2.64M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 14,816 | 7,665 | $1.82M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 20,332 | 19,418 | $1.71M |
| 99215 | Prolong outpt/office vis | 9,308 | 8,414 | $1.66M |
| 96415 | 1,726 | 1,481 | $1.48M | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 5,735 | 3,925 | $1.24M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5,543 | 5,245 | $1.23M |
| S9485 | Crisis intervention mental health services, per diem | 576 | 527 | $1.09M |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 37,608 | 2,935 | $1.07M |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,013 | 2,563 | $1.01M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,242 | 3,498 | $1.00M |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 691 | 657 | $963K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,114 | 1,103 | $887K |
| 90834 | Psychotherapy, 45 minutes with patient | 6,624 | 4,570 | $871K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,523 | 2,506 | $850K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,223 | 2,166 | $813K |
| 80053 | Comprehensive metabolic panel | 38,853 | 33,300 | $799K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,912 | 3,756 | $732K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1,725 | 1,709 | $666K |
| G0378 | Hospital observation service, per hour | 3,756 | 2,892 | $654K |
| 87631 | 4,989 | 4,911 | $623K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,117 | 2,091 | $588K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 301 | 301 | $564K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,863 | 2,784 | $544K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13,399 | 13,111 | $508K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1,135 | 1,121 | $478K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 441 | 434 | $461K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 455 | 450 | $456K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13,334 | 13,046 | $454K |
| 97161 | 2,694 | 2,664 | $451K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 17,328 | 15,371 | $437K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,837 | 1,674 | $401K |
| 90832 | Psychotherapy, 30 minutes with patient | 3,952 | 2,984 | $399K |
| H0040 | Assertive community treatment program, per diem | 230 | 229 | $397K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 7,966 | 7,916 | $376K |
| D9223 | Deep sedation/general anesthesia - each subsequent 15 minute increment | 573 | 573 | $374K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,349 | 1,046 | $372K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 8,097 | 5,830 | $357K |
| 90837 | Psychotherapy, 53 minutes with patient | 2,595 | 1,753 | $332K |
| 76770 | 1,618 | 1,599 | $332K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 12,899 | 12,400 | $319K |
| 59025 | Fetal non-stress test | 1,041 | 585 | $301K |
| 92567 | 2,340 | 2,333 | $252K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 17,665 | 17,529 | $247K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 892 | 753 | $244K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 7,808 | 7,702 | $243K |
| 86850 | 5,869 | 4,724 | $239K | |
| 84443 | Thyroid stimulating hormone (TSH) | 19,350 | 18,970 | $229K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 363 | 353 | $225K |
| 95812 | 518 | 516 | $224K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 10,028 | 6,954 | $221K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,084 | 1,073 | $208K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 4,960 | 4,956 | $207K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,973 | 1,202 | $194K |
| 97162 | 936 | 924 | $190K | |
| 87536 | 1,392 | 1,377 | $190K | |
| D9222 | 556 | 556 | $189K | |
| 92134 | 1,433 | 1,377 | $189K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 7,521 | 7,476 | $186K |
| 86901 | 6,048 | 4,902 | $164K | |
| 80061 | Lipid panel | 16,806 | 16,728 | $161K |
| 80051 | 4,364 | 3,921 | $156K | |
| 92557 | 1,364 | 1,357 | $156K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 86 | 86 | $152K |
| 99205 | Prolong outpt/office vis | 774 | 766 | $149K |
| 80076 | 7,808 | 7,294 | $145K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,293 | 2,191 | $140K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 48,096 | 41,197 | $140K |
| 86780 | 7,627 | 7,560 | $135K | |
| 36415 | Collection of venous blood by venipuncture | 41,941 | 35,507 | $131K |
| 93320 | 1,607 | 1,575 | $124K | |
| 86900 | 6,036 | 4,894 | $121K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 6,148 | 6,143 | $120K |
| 94010 | 676 | 668 | $112K | |
| 84439 | 9,676 | 9,434 | $111K | |
| 94060 | 332 | 331 | $111K | |
| 93325 | 1,938 | 1,868 | $109K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,641 | 2,553 | $106K |
| 86803 | 7,802 | 7,755 | $105K | |
| 82728 | 6,601 | 6,321 | $103K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5,610 | 4,447 | $102K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 11,532 | 10,904 | $101K |
| 83880 | 2,037 | 1,771 | $99K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 475 | 475 | $96K |
| 92133 | 569 | 565 | $94K | |
| 97803 | 1,677 | 1,619 | $94K | |
| 86480 | 1,124 | 1,113 | $88K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 105 | 105 | $87K |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | 519 | 78 | $84K |
| 87522 | Neg quan hep c or qual rna | 1,253 | 1,226 | $84K |
| 82607 | 5,044 | 5,012 | $83K | |
| 92579 | 752 | 748 | $81K | |
| 84403 | 2,504 | 2,461 | $81K | |
| 93975 | 249 | 223 | $80K | |
| 87340 | 5,524 | 5,482 | $76K | |
| 86360 | 1,494 | 1,473 | $75K | |
| 83970 | 1,169 | 1,141 | $74K | |
| 87480 | 4,517 | 4,432 | $73K | |
| Q9956 | Injection, octafluoropropane microspheres, per ml | 1,438 | 760 | $73K |
| 87510 | 4,517 | 4,432 | $73K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 9,446 | 5,312 | $72K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 38 | 38 | $71K |
| 95886 | 455 | 452 | $69K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1,698 | 1,319 | $67K |
| 93017 | 350 | 345 | $66K | |
| 82670 | 1,547 | 1,530 | $65K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 70 | 68 | $64K |
| 88342 | 1,154 | 1,072 | $62K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 305 | 196 | $61K |
| 87660 | 4,656 | 4,551 | $61K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,574 | 859 | $57K |
| 83655 | 2,851 | 2,833 | $56K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 131 | 129 | $54K |
| 86359 | 1,510 | 1,488 | $53K | |
| 87081 | 8,903 | 8,739 | $52K | |
| 97010 | 1,987 | 1,093 | $52K | |
| 76882 | 369 | 367 | $51K | |
| 85610 | 8,648 | 6,735 | $50K | |
| 86706 | 3,811 | 3,783 | $49K | |
| 85027 | 14,456 | 12,334 | $46K | |
| 88185 | 419 | 197 | $45K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 143 | 139 | $45K |
| 86704 | 3,566 | 3,537 | $45K | |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | 13 | 12 | $43K |
| 95951 | 164 | 82 | $41K | |
| 86762 | 1,859 | 1,855 | $39K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 11,946 | 11,387 | $39K |
| 83540 | 6,233 | 6,085 | $39K | |
| H2011 | Crisis intervention service, per 15 minutes | 511 | 296 | $38K |
| 88341 | 670 | 416 | $37K | |
| 82570 | 5,242 | 5,031 | $36K | |
| 84702 | 2,628 | 2,149 | $35K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,894 | 1,773 | $35K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 12 | 12 | $35K |
| D1120 | Prophylaxis - child | 444 | 444 | $33K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 91 | 91 | $33K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 522 | 261 | $32K |
| 97165 | 223 | 221 | $32K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 75 | 74 | $31K |
| 83735 | 8,455 | 5,636 | $30K | |
| 87186 | 3,536 | 3,417 | $30K | |
| 86708 | 2,204 | 2,201 | $30K | |
| 86140 | 7,165 | 6,466 | $29K | |
| 84146 | 989 | 976 | $29K | |
| 76830 | Ultrasound, transvaginal | 734 | 730 | $29K |
| J2704 | Injection, propofol, 10 mg | 9,487 | 9,342 | $29K |
| 82746 | 1,811 | 1,794 | $28K | |
| 95720 | 209 | 104 | $28K | |
| 97802 | 591 | 589 | $28K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 98 | 98 | $27K |
| 93971 | 404 | 371 | $27K | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 1,240 | 1,211 | $27K |
| 82784 | 2,258 | 2,083 | $26K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 360 | 207 | $26K |
| 83001 | 970 | 963 | $26K | |
| 81001 | 8,217 | 7,708 | $26K | |
| 83550 | 3,969 | 3,866 | $25K | |
| 82043 | 3,355 | 3,332 | $25K | |
| A9573 | Injection, gadopiclenol, 1 ml | 505 | 296 | $24K |
| 97164 | 224 | 221 | $23K | |
| 71046 | Radiologic examination, chest; 2 views | 6,178 | 5,936 | $23K |
| 80069 | 1,516 | 1,347 | $23K | |
| 84466 | 1,699 | 1,673 | $23K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 1,485 | 1,467 | $23K |
| 12001 | 39 | 39 | $22K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 3,390 | 2,884 | $21K |
| 87070 | 2,591 | 2,524 | $21K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 102 | 37 | $20K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 7,679 | 6,853 | $20K |
| 92083 | 167 | 166 | $20K | |
| 80197 | 1,978 | 992 | $20K | |
| 96367 | 160 | 118 | $20K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 54 | 54 | $20K |
| 84402 | 833 | 829 | $19K | |
| A9585 | Injection, gadobutrol, 0.1 ml | 626 | 621 | $18K |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 1,339 | 1,335 | $17K |
| 93976 | 105 | 103 | $17K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 816 | 799 | $17K |
| 76000 | 149 | 145 | $17K | |
| 90715 | 529 | 526 | $16K | |
| 92556 | 246 | 246 | $16K | |
| 88112 | 260 | 248 | $16K | |
| 92552 | 107 | 107 | $16K | |
| 86355 | 375 | 367 | $16K | |
| 59841 | 14 | 14 | $15K | |
| 74183 | 32 | 30 | $15K | |
| 84100 | 5,200 | 3,410 | $15K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 824 | 512 | $14K |
| 83002 | 520 | 516 | $13K | |
| 85652 | 6,283 | 5,871 | $13K | |
| 86038 | 1,722 | 1,712 | $12K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 76 | 55 | $12K |
| 70486 | 106 | 105 | $12K | |
| 82565 | 8,266 | 7,591 | $12K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 180 | 176 | $12K |
| 82805 | 551 | 513 | $12K | |
| 73610 | 1,814 | 1,707 | $12K | |
| 83690 | 8,703 | 7,966 | $12K | |
| 99223 | Prolong inpt eval add15 m | 72 | 72 | $11K |
| 83615 | 3,654 | 2,422 | $11K | |
| 73630 | 1,786 | 1,724 | $11K | |
| 85730 | 2,404 | 2,352 | $11K | |
| 88304 | 278 | 247 | $11K | |
| 84460 | 2,932 | 2,869 | $11K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,827 | 3,428 | $10K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 12 | 12 | $10K |
| 71250 | 97 | 95 | $10K | |
| 82105 | 1,165 | 1,119 | $10K | |
| 86357 | 364 | 356 | $10K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 966 | 893 | $10K |
| 0071A | 161 | 158 | $10K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 9,027 | 8,815 | $10K |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 697 | 697 | $9K |
| 84156 | 2,087 | 1,853 | $9K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 186 | 77 | $9K |
| 0001A | 243 | 240 | $9K | |
| 12002 | 14 | 14 | $9K | |
| 86787 | 933 | 927 | $9K | |
| 88307 | 90 | 77 | $9K | |
| 99222 | Initial hospital care, per day, moderate complexity | 85 | 85 | $9K |
| 92250 | 126 | 121 | $9K | |
| 82248 | 2,984 | 2,756 | $9K | |
| 81025 | 1,898 | 1,844 | $8K | |
| 73030 | 1,094 | 1,068 | $8K | |
| 76536 | 287 | 285 | $8K | |
| 86765 | 428 | 426 | $8K | |
| 99233 | Prolong inpt eval add15 m | 112 | 43 | $8K |
| 87102 | 959 | 947 | $8K | |
| 84450 | 1,328 | 1,304 | $8K | |
| 82950 | 995 | 994 | $8K | |
| 0002A | 126 | 126 | $8K | |
| 70498 | 56 | 55 | $8K | |
| 82150 | 8,229 | 7,555 | $8K | |
| 86481 | 106 | 105 | $7K | |
| 87529 | 88 | 88 | $7K | |
| 86618 | 339 | 338 | $7K | |
| 0012A | 136 | 136 | $7K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,608 | 1,494 | $7K |
| 85380 | 390 | 387 | $7K | |
| 86364 | 710 | 685 | $7K | |
| 0124A | 112 | 112 | $7K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 8,727 | 8,154 | $6K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 8,162 | 7,373 | $6K |
| 82550 | 1,621 | 1,494 | $6K | |
| 88184 | 253 | 235 | $6K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 107 | 107 | $6K |
| D7140 | Extraction, erupted tooth or exposed root | 12 | 12 | $6K |
| 85007 | 4,909 | 3,551 | $6K | |
| 87205 | 1,968 | 1,912 | $6K | |
| 95885 | 55 | 55 | $6K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 27 | 26 | $6K |
| 90686 | 438 | 437 | $6K | |
| 85014 | 2,037 | 1,973 | $6K | |
| 74018 | 1,400 | 1,350 | $6K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 91 | 91 | $6K |
| 73130 | 1,300 | 1,215 | $6K | |
| 82977 | 912 | 819 | $6K | |
| 72082 | 329 | 328 | $5K | |
| 93296 | 34 | 34 | $5K | |
| 86376 | 254 | 252 | $5K | |
| 88321 | 105 | 101 | $5K | |
| 72100 | 720 | 718 | $5K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 159 | 73 | $5K |
| J8540 | Dexamethasone, oral, 0.25 mg | 1,363 | 777 | $5K |
| 86430 | 757 | 756 | $5K | |
| 82247 | 2,689 | 2,531 | $5K | |
| 73562 | 812 | 801 | $5K | |
| 84550 | 1,084 | 900 | $5K | |
| 0011A | 155 | 155 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 12,256 | 11,154 | $5K |
| 87497 | 104 | 51 | $5K | |
| 81003 | 3,674 | 3,569 | $5K | |
| J1756 | Injection, iron sucrose, 1 mg | 121 | 72 | $5K |
| 74230 | 12 | 12 | $5K | |
| 72156 | 12 | 12 | $4K | |
| 84480 | 653 | 620 | $4K | |
| 73560 | 696 | 655 | $4K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 574 | 481 | $4K |
| D1208 | Topical application of fluoride, excluding varnish | 64 | 64 | $4K |
| 86923 | 102 | 48 | $4K | |
| 82040 | 2,481 | 2,401 | $4K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 1,595 | 1,078 | $4K |
| 82533 | 222 | 195 | $4K | |
| 93299 | 24 | 24 | $4K | |
| 83020 | 260 | 187 | $4K | |
| 99221 | 40 | 40 | $4K | |
| 0072A | 63 | 63 | $4K | |
| 82947 | 7,439 | 6,568 | $4K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 8,350 | 8,124 | $4K |
| 86735 | 326 | 325 | $4K | |
| 74178 | 29 | 29 | $3K | |
| 0004A | 58 | 58 | $3K | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 80 | 79 | $3K |
| 93225 | 13 | 13 | $3K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 281 | 281 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,906 | 1,731 | $3K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 304 | 143 | $3K |
| 88189 | 68 | 67 | $3K | |
| 88142 | 114 | 114 | $3K | |
| 73110 | 562 | 527 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 63 | 53 | $3K |
| 82785 | 193 | 193 | $3K | |
| 73502 | 449 | 437 | $3K | |
| 86160 | 197 | 102 | $3K | |
| 84075 | 1,863 | 1,822 | $3K | |
| 84165 | 382 | 300 | $3K | |
| 86800 | 132 | 132 | $3K | |
| 99443 | 24 | 20 | $2K | |
| 82310 | 2,257 | 2,169 | $2K | |
| 87338 | 205 | 205 | $2K | |
| 73590 | 463 | 419 | $2K | |
| 72170 | 278 | 276 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 12 | 12 | $2K |
| 96402 | 28 | 26 | $2K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 535 | 502 | $2K |
| 95909 | 27 | 27 | $2K | |
| 84155 | 2,350 | 2,269 | $2K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 342 | 324 | $2K |
| 84520 | 6,718 | 6,062 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,218 | 1,699 | $2K |
| 84481 | 158 | 157 | $2K | |
| J1644 | Injection, heparin sodium, per 1000 units | 1,281 | 1,102 | $2K |
| 97166 | 12 | 12 | $2K | |
| 92611 | 12 | 12 | $2K | |
| 94729 | 65 | 65 | $2K | |
| 87040 | 1,822 | 1,253 | $2K | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 857 | 736 | $2K |
| 31575 | 13 | 12 | $2K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 737 | 643 | $2K |
| 86696 | 121 | 120 | $2K | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 166 | 165 | $2K |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 96 | 74 | $2K |
| 85045 | 935 | 823 | $2K | |
| 84295 | 2,599 | 2,490 | $2K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 536 | 308 | $2K |
| 71045 | Radiologic examination, chest; single view | 1,505 | 1,448 | $2K |
| J1630 | Injection, haloperidol, up to 5 mg | 1,327 | 1,296 | $2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 43 | 42 | $2K |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 198 | 180 | $2K |
| 88313 | 168 | 126 | $2K | |
| D1351 | Sealant - per tooth | 12 | 12 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 26 | 26 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 768 | 667 | $2K |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | 25 | 13 | $1K |
| 86235 | 52 | 52 | $1K | |
| 86077 | 28 | 13 | $1K | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 820 | 808 | $1K |
| 73140 | 290 | 261 | $1K | |
| 93226 | 13 | 13 | $1K | |
| 87641 | 49 | 48 | $1K | |
| 84703 | 2,811 | 2,689 | $1K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 13 | 13 | $1K |
| 82435 | 2,291 | 2,211 | $1K | |
| 82374 | 2,089 | 2,019 | $1K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 313 | 224 | $1K |
| 86008 | 40 | 25 | $1K | |
| 93922 | 39 | 28 | $1K | |
| 85060 | 87 | 84 | $1K | |
| 88319 | 22 | 12 | $1K | |
| 83993 | 67 | 67 | $1K | |
| 86665 | 49 | 49 | $1K | |
| 73090 | 310 | 252 | $1K | |
| 87088 | 99 | 96 | $1K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 3,567 | 1,831 | $1K |
| 87158 | 1,791 | 1,759 | $1K | |
| 73564 | 66 | 65 | $1K | |
| 0031A | 17 | 17 | $1K | |
| 84132 | 864 | 825 | $997.35 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 637 | 632 | $991.22 |
| 85384 | 268 | 252 | $935.29 | |
| 76801 | 12 | 12 | $928.05 | |
| 87206 | 168 | 165 | $921.77 | |
| 73070 | 141 | 110 | $866.76 | |
| 73100 | 135 | 110 | $851.19 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 348 | 179 | $840.44 |
| 0054A | 14 | 14 | $840.00 | |
| 85097 | 12 | 12 | $815.20 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 367 | 365 | $805.31 |
| 88312 | 17 | 13 | $788.37 | |
| 86592 | 178 | 172 | $751.08 | |
| 83605 | 1,453 | 1,350 | $705.59 | |
| 73080 | 115 | 108 | $704.62 | |
| S9484 | Crisis intervention mental health services, per hour | 17 | 13 | $655.41 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 108 | 93 | $627.59 |
| 86769 | 12 | 12 | $568.80 | |
| 86225 | 77 | 77 | $568.71 | |
| 84153 | 27 | 27 | $551.80 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3,064 | 3,000 | $539.28 |
| G0008 | Administration of influenza virus vaccine | 32 | 32 | $521.04 |
| 84134 | 64 | 56 | $514.51 | |
| 85018 | 219 | 211 | $489.50 | |
| 82378 | 44 | 37 | $485.83 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 51 | 51 | $471.08 |
| 87535 | 12 | 12 | $440.62 | |
| V5266 | Battery for use in hearing device | 39 | 39 | $435.60 |
| 95911 | 12 | 12 | $435.42 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 212 | 211 | $434.49 |
| 86709 | 28 | 28 | $427.50 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 1,577 | 1,274 | $418.19 |
| 73552 | 87 | 81 | $417.49 | |
| 87184 | 26 | 26 | $401.42 | |
| 84484 | 3,827 | 2,018 | $401.16 | |
| 97035 | 18 | 12 | $352.44 | |
| 83521 | 42 | 14 | $320.70 | |
| 82330 | 224 | 213 | $314.03 | |
| 86304 | 12 | 12 | $312.20 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 1,074 | 910 | $310.90 |
| 87324 | 44 | 41 | $282.00 | |
| 82390 | 25 | 25 | $255.15 | |
| 83525 | 13 | 13 | $205.80 | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 12 | 12 | $198.24 |
| 86308 | 50 | 49 | $196.53 | |
| Q0164 | Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 367 | 208 | $196.22 |
| 87449 | 31 | 30 | $195.00 | |
| 86301 | 13 | 12 | $187.32 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 2,649 | 2,454 | $176.70 |
| 87015 | 27 | 27 | $170.54 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,594 | 1,572 | $167.27 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 909 | 828 | $151.77 |
| 87116 | 13 | 13 | $141.93 | |
| 72040 | 15 | 14 | $136.40 | |
| J1815 | Injection, insulin, per 5 units | 92 | 41 | $133.71 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 122 | 122 | $125.88 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 13 | 13 | $117.81 |
| 87075 | 28 | 27 | $113.68 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,756 | 4,303 | $90.34 |
| 83721 | 220 | 218 | $80.70 | |
| 72070 | 13 | 13 | $68.20 | |
| J2060 | Injection, lorazepam, 2 mg | 70 | 67 | $55.68 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 14 | 14 | $55.10 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 134 | 128 | $51.97 |
| 96375 | Therapeutic injection; each additional sequential IV push | 5,702 | 4,332 | $50.22 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 91 | 78 | $48.40 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 33 | 29 | $38.64 |
| 81002 | 1,383 | 1,347 | $36.20 | |
| 80143 | 989 | 927 | $25.44 | |
| 85390 | 399 | 371 | $20.15 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 12 | 12 | $15.60 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 16 | 14 | $14.98 |
| 80179 | 975 | 915 | $12.72 | |
| 88300 | 474 | 402 | $8.84 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,023 | 1,016 | $7.50 |
| 99153 | Mod sedat endo service >5yrs | 1,475 | 1,437 | $0.00 |
| C1769 | Guide wire | 1,046 | 1,024 | $0.00 |
| 96376 | 1,367 | 970 | $0.00 | |
| 82077 | 534 | 508 | $0.00 | |
| 95012 | 91 | 90 | $0.00 | |
| 96127 | 13 | 13 | $0.00 | |
| 99152 | 2,320 | 2,253 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 567 | 556 | $0.00 |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | 115 | 110 | $0.00 |
| 96417 | 87 | 50 | $0.00 | |
| 85347 | 38 | 38 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 263 | 258 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 99 | 99 | $0.00 |
| C1729 | Catheter, drainage | 13 | 13 | $0.00 |
| T1040 | Medicaid certified community behavioral health clinic services, per diem | 26 | 24 | $0.00 |
| 95800 | 12 | 12 | $0.00 |